Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Prenatal Multivitamin vs Raloxifene (Evista): Prenatal Multivitamin has the stronger overall evidence (7 vs 5.3/10); the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Prenatal Multivitamin wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
1 serving daily as labelled. The verified folic acid evidence rests on 400-800 mcg daily started before conception
with-meals
A prenatal containing 400-800 mcg folic acid, started at least one month before conception
Approved (postmenopausal women) / off-label (male) — clinician-directed. For osteoporosis treatment/prevention and breast-cancer risk reduction the standard, validated dose is 60 mg once daily (the MORE, CORE, RUTH and STAR trials all used 60 mg/day; MORE also tested 120 mg/day with no clear added fracture benefit and more side effects). For off-label male gynecomastia the small published pediatric series used roughly 60 mg/day; there is no FDA-approved male dose and the male evidence is thin and retrospective.
any
Raloxifene hydrochloride 60 mg tablets (approved for postmenopausal osteoporosis and breast-cancer risk reduction)
and 4 more not shown
Requires pre-conception start
Across pregnancy
Across pregnancy
n/a
Months to years
Years
Throughout use
Throughout use
Effects and safety of periconceptional oral folate supplementation for preventing birth defects.
Cochrane Database Syst Rev (2015) · Meta analysis
Neural tube defects: RR 0.31 (95% CI 0.17-0.58) across 5 studies, 6,708 births — HIGH quality evidence
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.
Lancet (1991) · Rct · n=1817
27 neural tube defects total: 6 in folic acid arms vs 21 in non-folic-acid arms — 72% protective effect, RR 0.28 (95% CI 0.12-0.71)
Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.
N Engl J Med (1992) · Rct · n=4753
The comparator was NOT placebo — it was a trace-element supplement (copper, manganese, zinc and a very low dose of vitamin C)
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
JAMA (1999) · Rct · n=7705
MORE: multicenter, randomized, double-blind, placebo-controlled trial of raloxifene 60 or 120 mg/day in 7,705 postmenopausal women with osteoporosis, followed up to 36 months
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
JAMA (1999) · Rct · n=7705
Pre-specified breast-cancer analysis of the MORE RCT (7,705 postmenopausal women with osteoporosis), followed a median 40 months
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.
J Natl Cancer Inst (2004) · Rct · n=5213
CORE: extension of the randomized MORE trial giving 4 additional years of raloxifene 60 mg/day (n=3,510) vs continued placebo (n=1,703)
Prenatal Multivitamin has a higher evidence score (7/10 vs 5.3/10) and wins in 3 of 3 categories.
No known interactions between Prenatal Multivitamin and Raloxifene (Evista) have been documented in our database. However, always consult a healthcare provider before combining supplements.
Folate is essential; inositol + CoQ10 are the best bets — but conception evidence is limited.
What’s safe while nursing, the truth about milk-supply herbs, and what to avoid (it passes into milk).
Safe, but no benefit if you’re not filling a gap. Who actually needs one — and who doesn’t.
Commonly recommended vs ask-your-clinician vs avoid — a general, safety-first overview.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.